Breaking News, Promotions & Moves

Freya Pharma Solutions Names Christa van Kan Director of Clinical Ops

Van Kan will oversee the company’s upcoming confirmatory clinical development program using Lybrido against FSIAD.

Freya Pharma Solutions, a late clinical stage company focusing on the development of pharmaceutical therapies for women diagnosed with Female Sexual Disorders (FSD), appointed Christa van Kan, director of clinical operations.  Van Kan brings more than 25 years of clinical operations and trial management experience to Freya Pharma Solutions. “Christa possesses more than 25 years of experience in the contract research organization (CRO) industry,” said Marcel Wijma, CEO, Freya Pha...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters